This study provides new insights into the regulation of PepT1 by EVs of the probiotic EcN in colonic epithelial cells under inflammatory conditions, emphasizing their potential use as a postbiotic strategy for treating IBD and associated cancer progression. This evidence concerns the gene SLC15A1 and cancer.